Eli Lilly and Company has taken the lead in in the production of tirzepatide, a groundbreaking treatment for type 2 diabetes. Tirzepatide, a dual GIP and GLP-1 receptor agonist, showcases significant potential to https://lulubjdk148525.bleepblogs.com/38707028/eli-lilly-s